Viatris Inc. , a global healthcare company, today announced the launch in Canada of Gen-Clozapine orally disintegrating tablets (ODT) (12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg), providing a new ...

Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement ...

Videos available at [ Key points A 94-year-old man with parkinsonism, followed in our geriatric medicine clinic, presented for routine follow-up, during which his wife reported that he had a ...